Metuchen, NJ, United States of America

Kevin Michael Belyk

This inventor holds 15 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Aicuris Anti-Infective Cures Gmbh. Active years: 1996-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Michael Belyk. Retrieved from https://idiyas.com/inventor/kevin-michael-belyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 80.0

 

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 68(Granted Patents)


Location History:

  • Woodbridge, NJ (US) (1996)
  • Somerset, NJ (US) (2007 - 2013)
  • Metchun, NJ (US) (2016)
  • Metuchen, NJ (US) (1999 - 2020)

Company Filing History:


Years Active: 1996-2020

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Mind of Kevin Michael Belyk

Introduction: Kevin Michael Belyk, a talented inventor based in Metuchen, NJ (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kevin Michael Belyk holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Kevin Michael Belyk has consistently pushed the boundaries of innovation, with a keen focus on developing cutting-edge technologies that have the potential to revolutionize industries.

Collaborations: Kevin Michael Belyk has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: In conclusion, Kevin Michael Belyk stands as a beacon of innovation in the field of technology, with a remarkable track record of pioneering inventions that have the power to shape the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…